Live from the NIH registry
Studies recruiting near Oxnard right now
Top 25 of 123 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Community Memorial Hospital — Ventura, California (8.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
Los Robles Regional Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: Abbott Medical Devices
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Dr. Karandeep Singh MD — Oxnard, California (0.3 mi)
· Sponsor: Pfizer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
UCLA Hematology/Oncology - Ventura — Ventura, California (8.5 mi)
· Sponsor: Pfizer
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Care Access Research — Thousand Oaks, California (19.7 mi)
· Sponsor: Novo Nordisk A/S
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Care Access Research — Thousand Oaks, California (19.7 mi)
· Sponsor: Boehringer Ingelheim
Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER)
Intracranial Aneurysm
N/A
Interventional 250 participants sought
Vascular and Neuroscience Institute of Southern California — Thousand Oaks, California (19.7 mi)
· Sponsor: Balt USA
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Non-segmental Vitiligo
Phase 2
Interventional 210 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (19.7 mi)
· Sponsor: Novartis Pharmaceuticals
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Bronchiectasis
Phase 3
Interventional 1,755 participants sought
Ventura County Medical Center — Ventura, California (8.5 mi)
· Sponsor: Boehringer Ingelheim
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Om Research, LLC 2 — Oxnard, California (0.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 1,500 participants sought
Clinical Trials Research Institute /ID# 258021 — Thousand Oaks, California (19.7 mi)
· Sponsor: AbbVie
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Ventura County Hematology Oncology Specialists — Oxnard, California (0.3 mi)
· Sponsor: Paradigm Health
Clinical Study of the inQB8 TTVR System (The MonarQ Study)
Tricuspid Valve Regurgitation
N/A
Interventional 50 participants sought
Los Robles Hosptial and Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: inQB8 Medical Technologies, LLC
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1029 — Thousand Oaks, California (19.7 mi)
· Sponsor: Immunovant Sciences GmbH
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Phase 3
Interventional 1,200 participants sought
Om Research LLC ( Site 5045) — Oxnard, California (0.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Phase 3
Interventional 1,800 participants sought
Fomat Medical Research — Oxnard, California (0.3 mi)
· Sponsor: Boehringer Ingelheim
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
HER2-negative Breast Cancer Patients With Brain Metastases
Phase 2
Interventional 120 participants sought
FOMAT Medical Research (Network) — Oxnard, California (0.3 mi)
· Sponsor: Biostar Pharma, Inc.
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
FOMAT - Allergy, Asthma & Immunology Medical Group — Ventura, California (8.5 mi)
· Sponsor: Celldex Therapeutics
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Ventura, California (8.5 mi)
· Sponsor: Medtronic
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Aortic Stenosis
N/A
Observational 225 participants sought
Los Robles Regional Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: Medtronic Cardiovascular
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 36 — Oxnard, California (0.3 mi)
· Sponsor: BioStem Technologies
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Androgenetic Alopecia
Phase 2, Phase 3
Interventional 600 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (19.7 mi)
· Sponsor: Pelage Pharmaceuticals, Inc.
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Venous Thromboembolism, Metastatic Pancreatic Cancer
Phase 3
Interventional 480 participants sought
Ventura Clinical Trials — Ventura, California (8.5 mi)
· Sponsor: Quercis Pharma AG
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 980 participants sought
Om Research, LLC - Oxnard - Site Number: 8400150 — Oxnard, California (0.3 mi)
· Sponsor: Sanofi
A Study of SL-325 in Crohn's Disease Patients
Crohn's Disease
Phase 2
Interventional 232 participants sought
Clinical Trial Site — Oxnard, California (0.3 mi)
· Sponsor: Shattuck Labs, Inc.